4-cresol-sulfate and Sepsis

4-cresol-sulfate has been researched along with Sepsis* in 1 studies

Other Studies

1 other study(ies) available for 4-cresol-sulfate and Sepsis

ArticleYear
Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury.
    International urology and nephrology, 2019, Volume: 51, Issue:2

    There is a gradual increase in serum concentrations of protein-bound colon-derived uremic toxins indoxyl sulphate (IxS) and p-cresyl sulphate (pCS) as chronic kidney disease (CKD) progresses. In acute kidney injury (AKI), up till now, the retention pattern has not been studied.. In this study, 194 adult patients admitted with sepsis to the intensive care unit were included. IxS, pCS and serum creatinine (sCrea) were quantified at inclusion (D0) and at day 4, unless follow-up ended earlier (D. Serum levels of sCrea (P < 0.001), IxS (P < 0.001) and pCS (P < 0.05) were higher in patients with AKI according to RIFLE classification at D0. In contrast with sCrea, IxS and pCS levels only increased from stage I (IxS) and F (pCS) on. When grouped according to evolution in RIFLE class from D0 to D. Although concentrations of IxS and pCS both tend to rise in sepsis patients with AKI, their evolution does not conform with that of sCrea. For the same level of sCrea, IxS and pCS concentrations are lower in AKI compared with CKD.

    Topics: Acute Kidney Injury; Aged; Belgium; Correlation of Data; Creatinine; Cresols; Female; Humans; Indican; Male; Middle Aged; Sepsis; Sulfuric Acid Esters; Time Factors; Uremia

2019